Lisata Therapeutics Stock Target Price and Analyst Consensus
| LSTA Stock | USD 2.76 0.06 2.13% |
The current analyst and expert consensus on Lisata Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Lisata Therapeutics target price consensus is 11.83 with 2 analyst opinions. Check out Macroaxis Advice on Lisata Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.The most common way Lisata Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Lisata Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Lisata Therapeutics. We encourage you to use your own analysis of Lisata Therapeutics to validate this buy or sell advice. Lisata Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Lisata Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.3998.
Lowest Forecast 10.77 | Highest Forecast 13.13 | Target Price 11.83 |
Lisata |
It's important to approach Lisata Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Lisata Therapeutics Target Price Consensus
Lisata target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Lisata Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Strong Buy |
Most Lisata analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Lisata stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Lisata Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationLisata Therapeutics Target Price Projection
Lisata Therapeutics' current and average target prices are 2.76 and 11.83, respectively. The current price of Lisata Therapeutics is the price at which Lisata Therapeutics is currently trading. On the other hand, Lisata Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Lisata Therapeutics Market Quote on 30th of November 2024
Target Price
Analyst Consensus On Lisata Therapeutics Target Price
Lisata Therapeutics Analyst Ratings
Lisata Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Lisata Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Lisata Therapeutics' financials, market performance, and future outlook by experienced professionals. Lisata Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Lisata Therapeutics price targets
Lisata Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Lisata Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Lisata Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Lisata Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Lisata Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Lisata Therapeutics is a key component of Lisata Therapeutics valuation and have some predictive power on the future returns of a Lisata Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lisata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Cash Cows Invested few shares | |
 | Blockchain Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | FinTech Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Corona Opportunity Invested few shares | |
Check out Macroaxis Advice on Lisata Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Please note, the presentation of Lisata Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lisata Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lisata Therapeutics' management manipulating its earnings.